BHC240920C2500
- 5.40
- +0.39+7.78%
Bausch Health Newsroom
Jefferies Maintains Bausch Health(BHC.US) With Buy Rating, Raises Target Price to $10
Jefferies analyst Glen Santangelo maintains $Bausch Health(BHC.US)$ with a buy rating, and adjusts the target price from $9 to $10.According to TipRanks data, the analyst has a success rate of 55.3%
Express News | Bausch Health Companies Inc : Jefferies Raises Target Price to $10 From $9
Small U.S. Stocks Finish Mixed As Bausch Health Lead, LiveWire Group Lags
Bausch & Lomb May Be Worth About $28 a Share in Takeover - Analyst
Private equity is interested in acquiring Bausch + Lomb (BLCO.US), which has surged more than 5%.
According to foreign media reports, private equity firm intends to acquire Bausch & Lomb (BLCO.US), the stock rose 8.51% at the time of writing.
Eye Health Supplements Global Outlook & Forecasts 2024-2029 With Amway, Bausch Health Companies, Nature's Bounty, Vitabiotics, and ZeaVision Leading the $3.28 Billion Market - ResearchAndMarkets.com
Jefferies Maintains Bausch Health(BHC.US) With Buy Rating, Cuts Target Price to $9
Jefferies analyst Glen Santangelo maintains $Bausch Health(BHC.US)$ with a buy rating, and adjusts the target price from $13 to $9.According to TipRanks data, the analyst has a success rate of 54.5%
Bausch + Lomb's Stock Soars 14% on Report Company Is Considering Selling Itself
Bausch + Lomb Shares Up in Premarket Amid Sale Consideration
Bausch + Lomb Reportedly Exploring Sale to Handle Bausch Health Spinoff
Here's Why Bausch Health (BHC) Is a Strong Momentum Stock
Bausch Health Companies Says Cabtreo Gets Health Canada Approval
Health Canada Approves (Pr)CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Triple-Combination Topical Treatment for Acne Vulgaris in Patients 12 Years of Age and Older
Breakeven Is Near for Bausch Health Companies Inc. (NYSE:BHC)
Bausch Health Companies Inc. (NYSE:BHC) Institutional Owners May Be Pleased With Recent Gains After 25% Loss Over the Past Year
Bank Of Canada Cuts Rates Again As Inflation, Labor Market Cool: Canadian Stocks Rebound, Loonie Strengthens
Chou RRSP Fund's Strategic Exits and New Positions in Q2 2024: Spotlight on Bausch Health ...
Bausch Health Companies Inc. (BHC): Among Billionaire Carl Icahn's Top Stock Picks
Glenview Capital's Q2 Moves Include Selling Broadcom After Just One Quarter, Exiting Meta
Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners